[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biohaven Ltd (BHVN)

Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,189,157
  • Shares Outstanding, K 150,561
  • Annual Sales, $ 0 K
  • Annual Income, $ -738,820 K
  • EBIT $ -654 M
  • EBITDA $ -644 M
  • 60-Month Beta 1.26
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 17.04

Options Overview Details

View History
  • Implied Volatility 88.16% (+1.32%)
  • Historical Volatility 58.91%
  • IV Percentile 9%
  • IV Rank 4.89%
  • IV High 384.04% on 11/04/25
  • IV Low 72.95% on 12/31/25
  • Expected Move (DTE 10) 1.30 (8.98%)
  • Put/Call Vol Ratio 0.16
  • Today's Volume 1,163
  • Volume Avg (30-Day) 2,261
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 52,165
  • Open Int (30-Day) 57,407
  • Expected Range 13.19 to 15.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.72
  • Number of Estimates 8
  • High Estimate $-0.59
  • Low Estimate $-0.84
  • Prior Year $-1.64
  • Growth Rate Est. (year over year) +56.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.13 +10.36%
on 08/03/26
15.79 -8.23%
on 07/20/26
-1.06 (-6.82%)
since 07/10/26
3-Month
8.22 +76.28%
on 05/19/26
17.28 -16.15%
on 07/09/26
+5.41 (+59.58%)
since 05/11/26
52-Week
7.48 +93.72%
on 11/11/25
18.57 -21.95%
on 10/30/25
+1.08 (+8.05%)
since 08/11/25

Most Recent Stories

More News
Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

NEW HAVEN, Conn. , August 10, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and...

BHVN : 14.49 (-0.34%)
Biohaven's Pipeline Updates Could Finally Separate Perception From Commercial Reality

Barchart Research What to Expect from BHVN Earnings BHVN Generated August 7, 2026 Current Price $14.66 EPS Estimate $$-0.77 Consensus Rating Moderate Buy Average Move 5.97% Biohaven's Pipeline Updates...

BHVN : 14.49 (-0.34%)
Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

Infinitum founder and Groq board director brings frontier AI and technology-investing expertise to Biohaven as the company advances AI-enabled approaches to drug development

BHVN : 14.49 (-0.34%)
Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million

NEW HAVEN, Conn. , July 27, 2026 /PRNewswire/ -- Biohaven Ltd. and/or its wholly owned subsidiaries ("Biohaven") (NYSE: BHVN) and Yale University ("Yale") today announced that a federal jury in the...

BHVN : 14.49 (-0.34%)
Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload

Biohaven also announces new clinical supply agreement with Regeneron to evaluate BHV-1530 in combination with cemiplimab (Libtayo®)

BHVN : 14.49 (-0.34%)
Biohaven Announces Scientific Leadership Transitions

NEW HAVEN, Conn. , July 9, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven" or the "Company") today announced scientific leadership role transitions designed to accelerate drug innovation...

BHVN : 14.49 (-0.34%)
Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator

NEW HAVEN, Conn. , June 30, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing...

BHVN : 14.49 (-0.34%)
Stock Indexes Finish Sharply Higher as Tech Soars

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.25%. September E-mini...

GOOGL : 343.80 (-3.84%)
AVGO : 416.08 (-1.50%)
VZ : 47.27 (+0.51%)
AXON : 636.31 (+6.70%)
$IUXX : 29,525.48 (-0.33%)
ASML : 1,799.38 (+3.80%)
MLM : 553.67 (+0.75%)
ZNU26 : 108-150 (-0.01%)
IRDM : 49.38 (+0.12%)
ESU26 : 7,754.50 (+0.09%)
T : 24.50 (+1.87%)
STX : 820.52 (+2.44%)
Stock Indexes Push Higher as Megacap Tech Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) is up +0.73% today; the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.08%. September E-mini S&P futures...

GOOGL : 343.80 (-3.84%)
AAPL : 304.91 (-1.09%)
SNDK : 1,271.05 (+2.68%)
MLM : 553.67 (+0.75%)
TSLA : 332.81 (+0.58%)
AMD : 474.32 (+1.01%)
RBLX : 36.22 (-2.24%)
DOCS : 26.11 (+1.87%)
SPY : 770.56 (-0.32%)
META : 599.12 (+0.71%)
ADSK : 251.59 (-1.75%)
MU : 868.52 (+0.87%)
Stock Indexes Supported by Strength in Megacap Tech Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.59%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.67%. September E-mini S&P futures...

GOOGL : 343.80 (-3.84%)
AAPL : 304.91 (-1.09%)
INTU : 336.44 (+0.60%)
SNDK : 1,271.05 (+2.68%)
DDOG : 246.78 (-5.37%)
AXON : 636.31 (+6.70%)
TXN : 281.24 (+0.29%)
$IUXX : 29,525.48 (-0.33%)
MLM : 553.67 (+0.75%)
ZNU26 : 108-150 (-0.01%)
MSFT : 503.81 (-0.44%)
IRDM : 49.38 (+0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut....

See More

Key Turning Points

3rd Resistance Point 15.64
2nd Resistance Point 15.10
1st Resistance Point 14.80
Last Price 14.49
1st Support Level 13.96
2nd Support Level 13.42
3rd Support Level 13.12

See More

52-Week High 18.57
Last Price 14.49
Fibonacci 61.8% 14.33
Fibonacci 50% 13.02
Fibonacci 38.2% 11.71
52-Week Low 7.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.